Am J Hematol. 2008 Apr;83(4):315-7.

Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.

Kitawaki T, Kadowaki N, Kondo T, Ishikawa T, Ichinohe T, Teramukai S, Fukushima M, Kasai Y, Maekawa T, Uchiyama T.

Source

Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan.

Abstract

Induction of leukemia-specific immune responses is a promising treatment for acute myeloid leukemia. A 58-year-old woman received Wilms' tumor 1 (WT1) peptide- and keyhole limpet hemocyanin (KLH)-pulsed, donor-derived dendritic cell (DC) vaccination for AML relapse after allogeneic stem cell transplantation. The vaccination induced immune responses to the naive antigen KLH, whereas definitive immune responses to WT1 were not detected. Leukemia gradually progressed despite of vaccination. This study indicates that DC vaccination can induce an antigen-specific immune response in a patient after allogeneic stem cell transplantation, thus representing a viable strategy to induce antigen-specific immune responses in such patients.

PMID:: 18081032; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Wilm's Tumor - Genetic Alliance

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. [Blood. 1999]
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.
Reichardt VL, Okada CY, Liso A, Benike CJ, Stockerl-Goldstein KE, Engleman EG, Blume KG, Levy R. Blood. 1999 Apr 1; 93(7):2411-9.
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. [Blood. 2009]
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.
Keilholz U, Letsch A, Busse A, Asemissen AM, Bauer S, Blau IW, Hofmann WK, Uharek L, Thiel E, Scheibenbogen C. Blood. 2009 Jun 25; 113(26):6541-8. Epub 2009 Apr 23.
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. [Blood. 1999]
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy.
Massaia M, Borrione P, Battaglio S, Mariani S, Beggiato E, Napoli P, Voena C, Bianchi A, Coscia M, Besostri B, et al. Blood. 1999 Jul 15; 94(2):673-83.
Review Peptide vaccines for patients with acute myeloid leukemia. [Expert Rev Vaccines. 2009]
Review Peptide vaccines for patients with acute myeloid leukemia.
Schmitt M, Casalegno-Garduño R, Xu X, Schmitt A. Expert Rev Vaccines. 2009 Oct; 8(10):1415-25.
Review WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide. [Anticancer Agents Med Chem. 2009]
Review WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.
Oka Y, Tsuboi A, Fujiki F, Li Z, Nakajima H, Hosen N, Shirakata T, Nishida S, Oji Y, Kawase I, et al. Anticancer Agents Med Chem. 2009 Sep; 9(7):787-97. Epub 2009 Sep 1.

See reviews... See all...

Cited by 3 PubMed Central articles

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. [Sci Transl Med. 2010]
Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells.
Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S, Uchida N, Suzuki N, Sone A, Najima Y, et al. Sci Transl Med. 2010 Feb 3; 2(17):17ra9.
Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. [Blood. 2010]
Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner.
Toubai T, Malter C, Tawara I, Liu C, Nieves E, Lowler KP, Sun Y, Reddy P. Blood. 2010 Jan 21; 115(3):724-35. Epub 2009 Nov 18.
Review Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. [Best Pract Res Clin Haematol. ...]
Review Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
Williams KM, Gress RE. Best Pract Res Clin Haematol. 2008 Sep; 21(3):579-96.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoi...
Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
Am J Hematol. 2008 Apr ;83(4):315-7.

PubMed
Quality of life, symptom distress, and social support among renal transplant rec...
Quality of life, symptom distress, and social support among renal transplant recipients in Southern Taiwan: a correlational study.
J Nurs Res. 2007 Dec ;15(4):319-29.

PubMed
Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynom...
Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
Arch Virol. 2008 ;153(3):463-72. Epub 2007 Dec 15 .

PubMed
A literature review describing the role of return-to-work coordinators in trial ...
A literature review describing the role of return-to-work coordinators in trial programs and interventions designed to prevent workplace disability.
J Occup Rehabil. 2008 Mar ;18(1):2-15. Epub 2007 Dec 15 .

PubMed
Cigarette smoking and risk of epithelial ovarian cancer.
Cigarette smoking and risk of epithelial ovarian cancer.
Cancer Causes Control. 2008 May ;19(4):413-20. Epub 2007 Dec 15 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: